Location: Mountain View, CA
CIK: 0001652044 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 4, 2023
Total Value: $1.861B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PATH | UiPath Inc | 14,068,674 | $233M | 12.5% | $73.33 | -78.1% | CL A | 90364P105 |
| — | Verve Therapeutics Inc | 10,549,086 | $198M | 10.6% | $60.25 | — | COM | 92539P101 |
| OSCR | Oscar Health Inc. | 24,042,864 | $194M | 10.4% | $31.30 | -76.4% | CL A | 687793109 |
| CRWD | Crowdstrike Hldgs Inc | 1,283,683 | $189M | 10.1% | $128.16 | +8.7% | CL A | 22788C105 |
| PRME | Prime Medicine, Inc. | 11,862,498 | $174M | 9.3% | $18.06 | -22.7% | COM | 74168J101 |
| DXCM | Dexcom Inc | 1,212,806 | $156M | 8.4% | $85.03 | +42.2% | COM | 252131107 |
| GTLB | Gitlab Inc. | 2,647,312 | $135M | 7.3% | $43.01 | -13.6% | CLASS A COM | 37637K108 |
| PL | Planet Labs Inc. | 31,942,641 | $103M | 5.5% | $9.47 | -58.2% | COM CL A | 72703X106 |
| SNOW | Snowflake Inc | 535,604 | $94.26M | 5.1% | $258.49 | -37.1% | CL A | 833445109 |
| — | EQRx Inc. | 47,675,476 | $88.68M | 4.8% | $6.82 | — | COM | 26886C107 |
| FRSH | Freshworks Inc | 4,035,595 | $70.95M | 3.8% | $36.28 | -58.5% | CLASS A COM | 358054104 |
| LYFT | Lyft Inc | 3,702,054 | $35.5M | 1.9% | $78.29 | -87.7% | CL A COM | 55087P104 |
| — | Benson Hill Inc. | 15,352,271 | $19.96M | 1.1% | $6.98 | — | COMMON STOCK | 082490103 |
| RLAY | Relay Therapeutics Inc. | 1,568,753 | $19.7M | 1.1% | $37.40 | -66.7% | COM | 75943R102 |
| — | Desktop Metal Inc. | 11,048,730 | $19.56M | 1.1% | $17.20 | — | COM CL A | 25058X105 |
| — | Lyell Immunopharma Inc. | 5,865,125 | $18.65M | 1.0% | $16.24 | — | COM | 55083R104 |
| SANA | Sana Biotechnology Inc. | 2,812,500 | $16.76M | 0.9% | $32.56 | -82.3% | COM | 799566104 |
| BEAM | Beam Therapeutics Inc. | 321,604 | $10.27M | 0.6% | $21.73 | +49.3% | COM | 07373V105 |
| — | RAPT Therapeutics Inc. | 540,270 | $10.1M | 0.5% | $27.61 | — | COM | 75382E109 |
| GLUE | Monte Rosa Therapeutics Inc. | 1,464,015 | $10.03M | 0.5% | $20.37 | -68.2% | COM | 61225M102 |
| ILMN | Illumina Inc. | 53,470 | $10.03M | 0.5% | $459.88 | -56.0% | COM | 452327109 |
| — | Decibel Therapeutics Inc. | 1,636,258 | $6.3M | 0.3% | $11.36 | — | COM | 24343R106 |
| HOOD | Robinhood Mkts Inc | 612,214 | $6.11M | 0.3% | $45.49 | -79.5% | COM CL A | 770700102 |
| IVVD | Invivyd Inc. | 5,680,785 | $5.965M | 0.3% | $37.11 | -96.6% | COM | 00534A102 |
| TNYA | Tenaya Therapeutics Inc. | 915,705 | $5.375M | 0.3% | $21.49 | -73.0% | COM | 87990A106 |
| VERA | Vera Therapeutics Inc. | 301,580 | $4.84M | 0.3% | $15.54 | -41.9% | CL A | 92337R101 |
| FHTX | Foghorn Therapeutics Inc. | 500,901 | $3.526M | 0.2% | $19.16 | -63.5% | COM | 344174107 |
| BRNS | Vaccitech PLC | 1,513,644 | $3.118M | 0.2% | $16.78 | — | ADS | 91864C107 |
| TCRX | Tscan Therapeutics Inc. | 1,077,080 | $2.693M | 0.1% | $9.27 | -71.1% | COM | 89854M101 |
| — | Magenta Therapeutics Inc. | 3,339,138 | $2.538M | 0.1% | $13.50 | — | COM | 55910K108 |
| — | Kronos Bio Inc. | 1,438,232 | $2.474M | 0.1% | $29.87 | — | COM | 50107A104 |
| EXAS | Exact Sciences Corp | 23,205 | $2.179M | 0.1% | $105.58 | -26.1% | COM | 30063P105 |
| HYPR | Hyperfine Inc. | 898,720 | $1.932M | 0.1% | $9.78 | -83.3% | COM CL A | 44916K106 |
| RANI | Rani Therapeutics Hldgs Inc. | 448,492 | $1.848M | 0.1% | $16.59 | -72.0% | COM CL A | 753018100 |
| AUTL | Autolus Therapeutics PLC | 698,262 | $1.662M | 0.1% | $26.79 | — | SPON ADR | 05280R100 |
| SPRO | Spero Therapeutics Inc. | 889,979 | $1.29M | 0.1% | $12.27 | -86.1% | COM | 84833T103 |
| ALEC | Alector Inc. | 175,866 | $1.057M | 0.1% | $18.92 | -63.1% | COM | 014442107 |
| — | Science 37 Holdings Inc. | 3,207,260 | $674K | 0.0% | $12.47 | — | COM | 808644108 |
| OPRT | Oportun Finl Corp | 94,788 | $566K | 0.0% | $23.37 | -79.0% | COM | 68376D104 |
| TSHA | Taysha Gene Therapies Inc. | 640,882 | $423K | 0.0% | $23.52 | -96.9% | COM SHS | 877619106 |
| QNCX | Quince Therapeutics Inc | 189,122 | $286K | 0.0% | $29.87 | -94.8% | COM | 22053A107 |
| — | Invitae Corp | 235,606 | $266K | 0.0% | $26.17 | — | COM | 46185L103 |
| EVLO | Evelo Biosciences Inc. | 53,024 | $172K | 0.0% | $2.97 | 0.0% | COM NEW | 299734202 |
| MONDQ | Mondee Holdings Inc. | 18,420 | $164K | 0.0% | $11.16 | — | CLASS A COM | 465712107 |
| RGEN | Repligen Corp | 383 | $54,179 | 0.0% | $269.41 | -40.5% | COM | 759916109 |
| FULC | Fulcrum Therapeutics Inc | 14,262 | $47,065 | 0.0% | $11.14 | -73.6% | COM | 359616109 |
| HLTHQ | Cue Health Inc | 27,000 | $9,990 | 0.0% | $6.44 | — | COM | 229790100 |